Leukotriene Receptor Inhibitors

LTB₄

LTC₄/CysLT₂

LTD₄/CysLT₁

LTE₄

Leukotriene Receptor Inhibitors, Agonists & Antagonists

Product Name	LTB₄	LTC₄/CysLT₂	LTD₄/CysLT₁	LTE₄	Purity
MK-571 sodium			LTD₄, Ki: 0.22±0.15 nM (In guinea pig lung) LTD₄, Ki: 2.1±1.8 nM (In human lung) LTD₄, pA2: 10.5	LTE₄, pA2: 10.4	99.24%
Montelukast sodium			CysLT₁		99.84%
Zafirlukast			LTD₄		99.89%
Montelukast			CysLT₁		99.94%
Pranlukast		LTC₄, Ki: 5640 nM	LTD₄, Ki: 0.99 nM	LTE₄, Ki: 0.63 nM	98.18%
MK-571			LTD₄, Ki: 0.22 nM (In guinea pig lung) LTD₄, Ki: 2.1 nM (In human lung) LTD₄, pA2: 10.5 (on guinea pig ileum)	LTE₄, pA2: 10.4 (on guinea pig ileum)	98.66%
CP-105696	LTB₄, IC₅₀: 8.42±0.26 nM				99.81%
Fiboflapon	LTB₄, IC₅₀: 76 nM				99.50%
12S-HHT	BLT2				≥99.0%
BIIL-260 hydrochloride	LTB₄, Ki: 1.7 nM				99.90%
Nedocromil		LTC₄			98.02%
LY255283	LTB₄, IC₅₀: ~100 nM (LTB₄ binds to guinea pig lung membranes)				98.52%
Pranlukast hemihydrate		LTC₄, Ki: 5640 nM	LTD₄, Ki: 0.99 nM	LTE₄, Ki: 0.63 nM	99.28%
Gemilukast		CysLT₂, IC₅₀: 25 nM	CysLT₁, IC₅₀: 1.7 nM		99.50%
Veliflapon	LTB₄	LTC₄			99.48%
Etalocib	LTB₄				98.74%
(S)-Verapamil hydrochloride		LTC₄			98.30%
LY223982	LTB₄, IC₅₀: 13.2 nM				99.67%
5-O-Demethylnobiletin		LTC₄, IC₅₀: 0.35 μM			99.91%
Quinotolast sodium		LTC₄			98.38%
HAMI 3379		CysLT₂			99.76%
Darbufelone mesylate	LTB₄				99.65%
Fiboflapon sodium	LTB₄, IC₅₀: 76 nM				99.46%
RG-12525		LTC₄, IC₅₀: 2.6 nM (Guinea pig)	LTD₄, IC₅₀: 2.5 nM (Guinea pig)	LTE₄, IC₅₀: 7 nM (Guinea pig)	98.31%
Amelubant	LTB₄, Ki: 221 nM (in vital human granulocytes) LTB₄, Ki: 230 nM (in cell membranes)				99.11%
20-Carboxy-Leukotriene B4	BLT1				≥98.0%
Nedocromil sodium		LTC₄
CAY10789			CysLT₁, IC₅₀: 2.8 ± 0.3 μM		99.84%
KP496			LTD₄		99.79%
AS-35		LTC₄, IC₅₀: 8 nM (In isolated guinea pig ileum)	LTD₄, IC₅₀: 4 nM (In isolated guinea pig ileum)	LTE₄, IC₅₀: 3 nM (In isolated guinea pig ileum)
(Rac)-HAMI 3379		CysLT₂
Tipelukast			LTD₄, pA2: 6.41 (In guinea-pigs)	LTE₄, pA2: 6.45 (In guinea-pigs)	99.40%
Montelukast dicyclohexylamine			CysLT₁
BAY-u 9773		LTC₄	LTD₄
LTB4 antagonist 1	LTB₄
CP-195543	LTB₄
Triptinin B			LTD₄
BLT2 antagonist-1	BLT2, IC₅₀: 224 nM
SB-209247	LTB₄, Ki: 0.78 nM
BLT2 probe 1	BLT2
CP-96021			LTD₄, Ki: 34±5 nM
LTB4 antagonist 2	LTB₄, IC₅₀: 439 nM
Ablukast			LTD₄		99.36%
5-LOX-IN-6	LTB₄
Etalocib sodium	LTB₄
CysLT1 receptor antagonist-1			CysLT₁, IC₅₀: 3.9 μM
LM-1484		LTC₄	CysLT₁
RS-601			LTD₄
Quininib		CysLT₂, IC₅₀: 52 μM	CysLT₁, IC₅₀: 1.2 μM
CAY10583	BLT2
CP-96021 hydrochloride		LTC₄, Ki: 34 nM
DW-1350	LTB₄
CP-96486			LTD₄, Ki: 20 nM
Iralukast			CysLT₁, pKi: 7.8
ONO4057	LTB₄, IC₅₀: 0.7 μM
LTD4 antagonist 1			LTD₄, Ki: 0.57 nM
LY210073	LTB₄, IC₅₀: 6.2 nM
CI-949		LTC₄, IC₅₀: 0.5 μM	LTD₄, IC₅₀: 0.5 μM
YM158 free base			LTD₄, pA2: 8.87
Bunaprolast	LTB₄
LTB4-IN-1	LTB₄, IC₅₀: 70 nM

MedChemExpress (MCE) 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务，不为任何个人或者非科研性质的、非用于药证申报使用等其他用途提供服务。	站点地图隐私声明
沪ICP备15051369号-4 上海工商沪公网安备31011502019417 沪(浦)应急管危经许[2021]201709(QFYS) 营业执照（三证合一）
Copyright © 2013-2024 MedChemExpress. All Rights Reserved.

MedChemExpress (MCE) 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务，不为任何个人或者非科研性质的、非用于药证申报使用等其他用途提供服务。

站点地图隐私声明

沪ICP备15051369号-4